共 50 条
Successful therapy of discoid lupus erythematosus with efalizumab
被引:2
|作者:
Booken, N.
[1
]
Schumann, T.
[1
]
Fuchslocher, M.
[1
]
Goerdt, S.
[1
]
Goebeler, M.
[1
]
机构:
[1] Univ Heidelberg, Med Fak Mannheim, Klin Dermatol Venerol & Allergol, Univ Klinikum Mannheim, D-68135 Mannheim, Germany
来源:
关键词:
Discoid lupus erythematosus;
Treatment;
Efalizumab;
D O I:
10.1007/s00105-009-1767-4
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
The therapy of discoid lupus erythematosus (DLE) is occasionally a therapeutic challenge. Topical treatment is often not sufficient and therapy with antimalarials [(hydroxy-) chloroquine] not always successful. We report on a 50-year-old male patient with recalcitrant chronic DLE who experienced within 12 weeks at first improvement and then almost complete remission for 11 months after off-label application of the anti-CD11a antibody efalizumab.
引用
收藏
页码:246 / 249
页数:4
相关论文